[1]
|
Albakova, Z., Mangasarova, Y., Albakov, A. and Gorenkova, L. (2022) HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis. Frontiers in Oncology, 12, Article 829520. https://doi.org/10.3389/fonc.2022.829520
|
[2]
|
Bhatia, S., Diedrich, D., Frieg, B., Ahlert, H., Stein, S., et al. (2018). Targeting HSP90 Dimerization via the C Terminus Is Effective in Imatinib-Resistant CML and Lacks the Heat Shock Response. Blood, 132, 307-320. https://doi.org/10.1182/blood-2017-10-810986
|
[3]
|
Li, Z.N. and Luo, Y. (2023) HSP90 Inhibitors and Cancer: Prospects for Use in Targeted Therapies (Review). Oncology Reports, 49, Article No. 6. https://doi.org/10.3892/or.2022.8443
|
[4]
|
Birbo, B., Madu, E.E., Madu, C.O., Jain, A. and Lu, Y. (2021) Role of Hsp90 in Cancer. International Journal of Molecular Sciences, 22, Article 10317. https://doi.org/10.3390/ijms221910317
|
[5]
|
Bouchier-Hayes, L., Oberst, A., McStay, G.P., Connell, S., Tait, S.W.G., Dillon, C.P., Flanagan, J.M., Beere, H.M. and Green, D.R. (2009) Characterization of Cytoplasmic Caspase-2 Activation by Induced Proximity. Molecular Cell, 35, 830-840. https://doi.org/10.1016/j.molcel.2009.07.023
|
[6]
|
Chang, C., Tang, X., Woodley, D.T., Chen, M. and Li, W. (2023) The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep. Cells, 12, Article 277. https://doi.org/10.3390/cells12020277
|
[7]
|
Chen, S., Yu, Q. and Zhou, S. (2021) Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitors Plus Chemotherapy. Frontiers in Oncology, 11, Article 765115. https://doi.org/10.3389/fonc.2021.765115
|
[8]
|
Chiosis, G., Digwal, C.S., Trepel, J.B. and Neckers, L. (2023) Structural and Functional Complexity of HSP90 in Cellular Homeostasis and Disease. Nature Reviews Molecular Cell Biology, 24, 797-815. https://doi.org/10.1038/s41580-023-00640-9
|
[9]
|
Daunys, S., Matulis, D. and Petrikaitė, V. (2019) Synergistic Activity of Hsp90 Inhibitors and Anticancer Agents in Pancreatic Cancer Cell Cultures. Scientific Reports, 9, Article No. 16177. https://doi.org/10.1038/s41598-019-52652-1
|
[10]
|
Hagn, F., Lagleder, S., Retzlaff, M., Rohrberg, J., Demmer, O., Richter, K., Buchner, J. and Kessler, H. (2010) Structural Analysis of the Interaction Between Hsp90 and the Tumor Suppressor Protein P53. Nature Structural and Molecular Biology, 18, 1086-1093. https://doi.org/10.1038/nsmb.2114
|
[11]
|
Han, Y., Zhang, Y., Cui, L., Li, Z., Feng, H., Zhang, Y., Sun, D. and Ren, L. (2021) Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: In Patients with Different Clinicopathologic Characteristics. World Journal of Surgical Oncology, 19, Article No. 228. https://doi.org/10.1186/s12957-021-02269-4
|
[12]
|
Li, W., Sahu, D. and Tsen, F. (2012) Secreted Heat Shock Protein-90 (Hsp90) in Wound Healing and Cancer. Biochimica Et Biophysica Acta-Molecular Cell Research, 1823, 730-741. https://doi.org/10.1016/j.bbamcr.2011.09.009
|
[13]
|
Hoter, A., El-Sabban, M.E. and Naim, H.Y. (2018) The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease. International Journal of Molecular Sciences, 19, Article 2560. https://doi.org/10.3390/ijms19092560
|
[14]
|
Hou, Q., Chen, S., An, Q., Li, B., Fu, Y. and Luo, Y. (2021) Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer. International Journal of Molecular Sciences, 22, Article 7747. https://doi.org/10.3390/ijms22147747
|
[15]
|
Jhaveri, K., Taldone, T., Modi, S. and Chiosis, G. (2012) Advances in the Clinical Development of Heat Shock Protein 90 (Hsp90) Inhibitors in Cancers. Biochimica et Biophysica Acta-Molecular Cell Research, 1823, 742-755. https://doi.org/10.1016/j.bbamcr.2011.10.008
|
[16]
|
Kim, J.Y., Cho, T.M., Park, J.M., Park, S., Park, M., et al. (2022). A Novel HSP90 Inhibitor SL-145 Suppresses Metastatic Triple-Negative Breast Cancer Without Triggering the Heat Shock Response. Oncogene, 41, 3289-3297. https://doi.org/10.1038/s41388-022-02269-y
|
[17]
|
Li, X., Tong, X., Liu, B., Li, Z., Ding, J., Li, J., Zheng, M., Tian, Y., Yan, S., Huang, M. and Ge, J. (2021) Potential Predictive Value of Plasma Heat Shock Protein 90α in Lung Cancer. Journal of International Medical Research, 49, 1-9. https://doi.org/10.1177/03000605211064393
|
[18]
|
Liang, X.Q., Li, K-Z., Li, Z., Xie, M.-Z., Tang, Y.-P., et al. (2021). Diagnostic and Prognostic Value of Plasma Heat Shock Protein 90alpha in Gastric Cancer. International Immunopharmacology, 90, Article 107145. https://doi.org/10.1016/j.intimp.2020.107145
|
[19]
|
Liu, L., Deng, Y., Zheng, Z., Deng, Z., Zhang, J., Li, J., Liang, M., Zhou, X., Tan, W., Yang, H., Neckers, L. M., Zou, F. and Chen, X. (2021) Hsp90 Inhibitor STA9090 Sensitizes Hepatocellular Carcinoma to Hyperthermia-Induced DNA Damage by Suppressing DNA-PKcs Protein Stability and MRNA Transcription. Molecular Cancer Therapeutics, 20, 1880-1892. https://doi.org/10.1158/1535-7163.MCT-21-0215
|
[20]
|
Mishra, S.J., Khandelwal, A., Banerjee, M., Balch, M., Peng, S., Davis, R.E., Merfeld, T., Munthali, V., Deng, J., Matts, R.L. and Blagg, B.S.J. (2021) Selective Inhibition of the Hsp90α Isoform. Angewandte Chemie International Edition, 60, 10547-10551. https://doi.org/10.1002/anie.202015422
|
[21]
|
Boysen, M., Kityk, R. and Mayer, M.P. (2019) Hsp70-and Hsp90-Mediated Regulation of the Conformation of P53 DNA Binding Domain and P53 Cancer Variants. Molecular Cell, 74, 831-843.E4. https://doi.org/10.1016/j.molcel.2019.03.032
|
[22]
|
Müller, L., Schaupp, A., Walerych, D., Wegele, H. and Buchner, J. (2004) Hsp90 Regulates the Activity of Wild Type P53 under Physiological and Elevated Temperatures. Journal of Biological Chemistry, 279, 48846-48854. https://doi.org/10.1074/jbc.M407687200
|
[23]
|
Nakanishi, M., Morita, Y., Hata, K. and Muragaki, Y. (2016) Acidic Microenvironments Induce Lymphangiogenesis and IL-8 Production via TRPV1 Activation in Human Lymphatic Endothelial Cells. Experimental Cell Research, 345, 180-189. https://doi.org/10.1016/j.yexcr.2016.06.006
|
[24]
|
Neckers, L. and Workman, P. (2012) Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? Clinical Cancer Research, 18, 64-76. https://doi.org/10.1158/1078-0432.CCR-11-1000
|
[25]
|
Park, H.K., Yoon, N.G., Lee, J.E., Hu, S., Yoon, S., Kim, S.Y., Hong, J.H., Nam, D., Chae, Y.C., Park, J.B. and Kang, B.H. (2020) Unleashing the Full Potential of Hsp90 Inhibitors as Cancer Therapeutics through Simultaneous Inactivation of Hsp90, Grp94, and TRAP1. Experimental and Molecular Medicine, 52, 79-91. https://doi.org/10.1038/s12276-019-0360-x
|
[26]
|
Shi, Y., Liu, X., Lou, J., Han, X., Zhang, L., Wang, Q., Li, B., Dong, M. and Zhang, Y. (2014) Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses. Clinical Cancer Research, 20, 6016-6022.
|
[27]
|
Somogyvári, M., Khatatneh, S. and Sőti, C. (2022) Hsp90: From Cellular to Organismal Proteostasis. Cells, 11, Article 2479. https://doi.org/10.3390/cells11162479
|
[28]
|
Taipale, M., Jarosz, D.F. and Lindquist, S. (2010) HSP90 at the Hub of Protein Homeostasis: Emerging Mechanistic Insights. Nature Reviews Molecular Cell Biology, 11, 515-528. https://doi.org/10.1038/nrm2918
|
[29]
|
Vogt, M., Dienstbier, N., Schliehe-Diecks, J., Scharov, K., Tu, J.W., et al. (2023) Co-Targeting HSP90 Alpha and CDK7 Overcomes Resistance Against HSP90 Inhibitors in BCR-ABL1+ Leukemia Cells. Cell Death and Disease, 14, Article No. 799. https://doi.org/10.1038/s41419-023-06337-3
|
[30]
|
Wei, W., Liu, M., Ning, S., Wei, J., Zhong, J., Li, J., Cai, Z. and Zhang, L. (2020) Diagnostic Value of Plasma HSP90α Levels for Detection of Hepatocellular Carcinoma. BMC Cancer, 20, Article No. 6. https://doi.org/10.1186/s12885-019-6489-0
|
[31]
|
Xue, N., Du, T., Lai, F., Jin, J., Ji, M. and Chen, X. (2022) Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer. International Journal of Molecular Sciences, 23, Article 5532. https://doi.org/10.3390/ijms23105532
|
[32]
|
Yuan, Z., Wang, L. and Chen, C. (2022) Analysis of the Prognostic, Diagnostic and Immunological Role of HSP90α in Malignant Tumors. Frontiers in Oncology, 12, Article 963719. https://doi.org/10.3389/fonc.2022.963719
|
[33]
|
Yuan, Z., Wang, L., Hong, S., Shi, C. and Yuan, B. (2022) Diagnostic Value of HSP90α and Related Markers in Lung Cancer. Journal of Clinical Laboratory Analysis, 36, e24462. https://doi.org/10.1002/jcla.24462
|
[34]
|
Zhang, S., Wang, C., Ma, B., Xu, M., Xu, S., Liu, J., Tian, Y., Fu, Y. and Luo, Y. (2020) Mutant P53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion. Cell Reports, 32, Article 107879. https://doi.org/10.1016/j.celrep.2020.107879
|
[35]
|
Zuehlke, A.D., Beebe, K., Neckers, L. and Prince, T. (2015) Regulation and Function of the Human HSP90AA1 Gene. Gene, 570, 8-16. https://doi.org/10.1016/j.gene.2015.06.018
|